Monoclonal antibodies (mAbs) are a major therapeutic modality. Grafting the meditope binding site onto mAbs, also known as meditope-enabling, can extend the usefulness of mAbs by providing an additional protein-protein interaction surface without altering the stability or antigen binding. We have previously used this site for attaching dyes, cytotoxic drugs, and entire proteins. Here, we provide a simple protocol for meditope-enabling mAbs, and verifying meditope and antigen binding using flow cytometry (FACS).
CITATION STYLE
King, J. D., & Williams, J. C. (2019). Refining the quality of monoclonal antibodies: Grafting unique peptide-binding site in the fab framework. In Methods in Molecular Biology (Vol. 1904, pp. 293–298). Humana Press Inc. https://doi.org/10.1007/978-1-4939-8958-4_12
Mendeley helps you to discover research relevant for your work.